Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA warns about sexual enhancement supplement

This article was originally published in The Tan Sheet

Executive Summary

The agency warns consumers Aug. 25 about TimeOut Capsules because they contain an undeclared ingredient. Hydroxythiohomosildenafil is similar to sildenafil, the FDA-approved ingredient in Pfizer's prescription Viagra, and may interact with nitrates to cause unsafe drops in blood pressure. "TimeOut is labeled as '100% natural' and consumers may mistakenly assume the product is harmless and poses no health risk," FDA said. The TimeOut warning is the latest in what has become a stready stream of alerts and recall announcements for so-called weight-loss and male enhancement supplements found to contain undeclared drugs (1"The Tan Sheet" Aug. 23, 2010, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel